These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 14211415)

  • 21. Phenelzine as a possible treatment for depression in schizophrenic patients.
    Melamed Y; Karniel E; Szor H
    Isr J Psychiatry Relat Sci; 1996; 33(3):211-2. PubMed ID: 9009521
    [No Abstract]   [Full Text] [Related]  

  • 22. Coadministration of phenelzine and methylphenidate for treatment-resistant depression.
    Shelton Clauson A; Elliott ES; Watson BD; Treacy J
    Ann Pharmacother; 2004 Mar; 38(3):508. PubMed ID: 14970373
    [No Abstract]   [Full Text] [Related]  

  • 23. Monoamine oxidase inhibitors phenelzine and brofaromine increase plasma serotonin and decrease 5-hydroxyindoleacetic acid in patients with major depression: relationship to clinical improvement.
    Celada P; Pérez J; Alvarez E; Artigas F
    J Clin Psychopharmacol; 1992 Oct; 12(5):309-15. PubMed ID: 1282522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. THREE EVALUATIONS OF A MONOAMINE OXIDASE INHIBITOR AND PHENOTHIAZINE COMBINATION (A METHODOLOGICAL AND CLINICAL STUDY).
    WINKELMANN W
    Dis Nerv Syst; 1965 Mar; 26():160-4. PubMed ID: 14262229
    [No Abstract]   [Full Text] [Related]  

  • 25. Combination monoamine oxidase inhibitor and beta-blocker treatment of migraine, with anxiety and depression.
    Merikangas KR; Merikangas JR
    Biol Psychiatry; 1995 Nov; 38(9):603-10. PubMed ID: 8573662
    [TBL] [Abstract][Full Text] [Related]  

  • 26. EARLY RECOGNITION OF DEPRESSION.
    FELLNER CH
    Geriatrics; 1964 Dec; 19():920-6. PubMed ID: 14226253
    [No Abstract]   [Full Text] [Related]  

  • 27. DROPOUT IN AN OUTPATIENT, DOUBLE-BLIND DRUG STUDY.
    GLICK BS
    Psychosomatics; 1965; 6():44-8. PubMed ID: 14263749
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of depression with an mao inhibitor followed by 5-HTP--an unfinished research project.
    Kline N; Sacks W
    Acta Psychiatr Scand Suppl; 1980; 280():233-41. PubMed ID: 6996430
    [No Abstract]   [Full Text] [Related]  

  • 29. [Classical monoamine oxidase inhibitor: not registered for, but still a place in the treatment of depression].
    Nolen WA
    Ned Tijdschr Geneeskd; 2003 Oct; 147(40):1940-3. PubMed ID: 14574774
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MAOIs in the contemporary treatment of depression.
    Thase ME; Trivedi MH; Rush AJ
    Neuropsychopharmacology; 1995 May; 12(3):185-219. PubMed ID: 7612154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. EXCRETION OF 3-METHOXY-4-HYDROXYMANDELIC ACID (VMA) IN DEPRESSED PATIENTS TREATED WITH ANTIDEPRESSANT DRUGS.
    SCHILDKRAUT JJ; KLERMAN GL; HAMMOND R; FRIEND DG
    J Psychiatr Res; 1964 Dec; 2():257-66. PubMed ID: 14271965
    [No Abstract]   [Full Text] [Related]  

  • 32. Refractory depression treated with high doses of monoamine oxidase inhibitor.
    Guze BH; Baxter LR; Rego J
    J Clin Psychiatry; 1987 Jan; 48(1):31-2. PubMed ID: 3804984
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Continuation and maintenance treatments in major depression: the neglected role of monoamine oxidase inhibitors.
    Kennedy SH
    J Psychiatry Neurosci; 1997 Mar; 22(2):127-31. PubMed ID: 9074307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. EFFECTS OF THE MONOAMINE OXIDASE INHIBITORS ON THE GASTRIC SECRETION.
    ESPERBEN MT; FERRARI JP; MARQUILLO CL
    Med Exp Int J Exp Med; 1964; 11():370-6. PubMed ID: 14250118
    [No Abstract]   [Full Text] [Related]  

  • 35. [THE EFFECT OF A MONOAMINE OXIDASE INHIBITOR ON THE ELIMINATION OF BUFOTENIN AND ON THE SYMPTOMS OF CHRONIC NON-PRODUCTIVE SCHIZOPHRENIA].
    FISCHER E; HELLER B
    Ann Med Psychol (Paris); 1965 Apr; 123():614-22. PubMed ID: 14296667
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparison of five clinically used inhibitors of monoamine oxidase using the fluorescence microscopy method.
    Bartonícek V
    Med Pharmacol Exp Int J Exp Med; 1967; 16(2):142-6. PubMed ID: 5298397
    [No Abstract]   [Full Text] [Related]  

  • 37. Monoamine oxidase inhibitors.
    Lippmann S
    Am Fam Physician; 1986 Jul; 34(1):113-9. PubMed ID: 3728254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Continuation and maintenance treatment of major depression with the monoamine oxidase inhibitor phenelzine: a double-blind placebo-controlled discontinuation study.
    Robinson DS; Lerfald SC; Bennett B; Laux D; Devereaux E; Kayser A; Corcella J; Albright D
    Psychopharmacol Bull; 1991; 27(1):31-9. PubMed ID: 1862204
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MAO ACTIVITY IN RELATION TO DEPRESSION.
    FELDSTEIN A; HOAGLAND H; WONG KK; OKTEM MR; FREEMAN H
    Am J Psychiatry; 1964 Jun; 120():1192-4. PubMed ID: 14154756
    [No Abstract]   [Full Text] [Related]  

  • 40. ENZYMES AND DRUG SENSITIVITY. ACETYLATION POLYMORPHISMS.
    EVANS DA
    Proc R Soc Med; 1964 Jun; 57(6):508-11. PubMed ID: 14190873
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.